61 related articles for article (PubMed ID: 17368189)
1. Altered VDR-mediated transcriptional activity in prostate cancer stroma.
Hidalgo AA; Paredes R; Garcia VM; Flynn G; Johnson CS; Trump DL; Onate SA
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):731-6. PubMed ID: 17368189
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of nuclear receptors for vitamin D3 and glucocorticoids in prostate stroma cell microenvironment.
Hidalgo AA; Montecinos VP; Paredes R; Godoy AS; McNerney EM; Tovar H; Pantoja D; Johnson C; Trump D; Onate SA
Biochem Biophys Res Commun; 2011 Aug; 412(1):13-9. PubMed ID: 21763285
[TBL] [Abstract][Full Text] [Related]
3. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract][Full Text] [Related]
4. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
5. Dynamic and ligand-selective interactions of vitamin D receptor with retinoid X receptor and cofactors in living cells.
Choi M; Yamada S; Makishima M
Mol Pharmacol; 2011 Dec; 80(6):1147-55. PubMed ID: 21917910
[TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
[TBL] [Abstract][Full Text] [Related]
8. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
[TBL] [Abstract][Full Text] [Related]
10. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
11. VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.
Solomon JD; Heitzer MD; Liu TT; Beumer JH; Parise RA; Normolle DP; Leach DA; Buchanan G; DeFranco DB
Mol Cancer Res; 2014 Aug; 12(8):1166-80. PubMed ID: 24825850
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
14. DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells.
Ansems M; Karthaus N; Hontelez S; Aalders T; Looman MW; Verhaegh GW; Schalken JA; Adema GJ
Prostate; 2012 Dec; 72(16):1708-17. PubMed ID: 22473304
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.
Singh PK; Doig CL; Dhiman VK; Turner BM; Smiraglia DJ; Campbell MJ
J Steroid Biochem Mol Biol; 2013 Jul; 136():258-63. PubMed ID: 23098689
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
17. Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites.
Carlberg C; Dunlop TW; Saramäki A; Sinkkonen L; Matilainen M; Väisänen S
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):338-43. PubMed ID: 17234401
[TBL] [Abstract][Full Text] [Related]
18. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation enhances benzo[a]pyrene metabolism via CYP1A1 expression in macrophages.
Matsunawa M; Akagi D; Uno S; Endo-Umeda K; Yamada S; Ikeda K; Makishima M
Drug Metab Dispos; 2012 Nov; 40(11):2059-66. PubMed ID: 22837390
[TBL] [Abstract][Full Text] [Related]
20. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
